Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amnon Peled

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|June 23, 2009
Focal liver necrosis appears early after partial hepatectomy and is dependent on T cells and antigen delivery from the gutNoam Rudich, Gideon Zamir, Orit Pappo, et al.
Stem Cells (Dayton, Ohio)|March 26, 2005
Cycling G1 CD34+/CD38+ cells potentiate the motility and engraftment of quiescent G0 CD34+/CD38-/low severe combined immunodeficiency repopulating cellsTamara Byk, Joy Kahn, Orit Kollet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2013
Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140Katia Beider, Elena Ribakovsky, Michal Abraham, et al.
Blood|September 28, 2002
Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulationOrit Kollet, Isabelle Petit, Joy Kahn, et al.
Blood|December 22, 2005
Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11Michal Dagan-Berger, Rotem Feniger-Barish, Shani Avniel, et al.
Journal of Hematology & Oncology|October 10, 2022
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progressionKatia Beider, Valeria Voevoda-Dimenshtein, Ali Zoabi, et al.
British Journal of Haematology|April 14, 2016
Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemiaShubhchintan Randhawa, Byung S Cho, Dipanjan Ghosh, et al.
Oncotarget|December 20, 2014
Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotypeKatia Beider, Hanna Bitner, Merav Leiba, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 8, 2004
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasisMerav Darash-Yahana, Eli Pikarsky, Rinat Abramovitch, et al.
Frontiers in Immunology|April 23, 2025
Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1Shira Hagbi-Levi, Michal Abraham, Lika Gamaev, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Liver International : Official Journal of the International Association for the Study of the Liver|June 23, 2009
Focal liver necrosis appears early after partial hepatectomy and is dependent on T cells and antigen delivery from the gutNoam Rudich, Gideon Zamir, Orit Pappo, et al.
Stem Cells (Dayton, Ohio)|March 26, 2005
Cycling G1 CD34+/CD38+ cells potentiate the motility and engraftment of quiescent G0 CD34+/CD38-/low severe combined immunodeficiency repopulating cellsTamara Byk, Joy Kahn, Orit Kollet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2013
Targeting the CD20 and CXCR4 pathways in non-hodgkin lymphoma with rituximab and high-affinity CXCR4 antagonist BKT140Katia Beider, Elena Ribakovsky, Michal Abraham, et al.
Blood|September 28, 2002
Human CD34(+)CXCR4(-) sorted cells harbor intracellular CXCR4, which can be functionally expressed and provide NOD/SCID repopulationOrit Kollet, Isabelle Petit, Joy Kahn, et al.
Blood|December 22, 2005
Role of CXCR3 carboxyl terminus and third intracellular loop in receptor-mediated migration, adhesion and internalization in response to CXCL11Michal Dagan-Berger, Rotem Feniger-Barish, Shani Avniel, et al.
Journal of Hematology & Oncology|October 10, 2022
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progressionKatia Beider, Valeria Voevoda-Dimenshtein, Ali Zoabi, et al.
British Journal of Haematology|April 14, 2016
Effects of pharmacological and genetic disruption of CXCR4 chemokine receptor function in B-cell acute lymphoblastic leukaemiaShubhchintan Randhawa, Byung S Cho, Dipanjan Ghosh, et al.
Oncotarget|December 20, 2014
Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotypeKatia Beider, Hanna Bitner, Merav Leiba, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 8, 2004
Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasisMerav Darash-Yahana, Eli Pikarsky, Rinat Abramovitch, et al.
Frontiers in Immunology|April 23, 2025
Identification of Dinaciclib and Ganetespib as anti-inflammatory drugs using a novel HTP screening assay that targets IFNγ-dependent PD-L1Shira Hagbi-Levi, Michal Abraham, Lika Gamaev, et al.
Pageof 9